Cargando…

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease

To investigate the efficacy and safety of Tocilizumab (TCZ) in patients with refractory adult-onset Still’s disease (AOSD). We enrolled 8 female patients from October 2013 to July 2014. All patients fulfilled Japan’s Yamaguch AOSD classification and recognized as refractory AOSD. All Patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ting, Gu, Liyang, Wang, Xiaodong, Guo, Li, Shi, Hui, Yang, Chengde, Chen, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647407/ https://www.ncbi.nlm.nih.gov/pubmed/29044212 http://dx.doi.org/10.1038/s41598-017-13639-y

Ejemplares similares

Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2018)

Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate: A STROBE-compliant article
por: Wang, Chun-yan, et al.
Publicado: (2019)

Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab
por: Imaizumi, Chihiro, et al.
Publicado: (2022)

Refractory Adult Onset Still’s Disease
por: Sulaiman, Wahinuddin, et al.
Publicado: (2017)

Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease
por: Drepper, Michael, et al.
Publicado: (2013)

Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
por: Hu, Qiongyi, et al.
Publicado: (2020)

Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study
por: Wan, Liyan, et al.
Publicado: (2022)

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses
por: Jia, Jinchao, et al.
Publicado: (2019)

Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still’s Disease
por: Sun, Ziyi, et al.
Publicado: (2023)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

Successful Treatment of Recurrent Adult-Onset Still’s Disease with Tocilizumab: A Case Report and Literature Review
por: Zhong, Xiaojing, et al.
Publicado: (2023)

Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease
por: Tsurukawa, Shinichiro, et al.
Publicado: (2016)

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
por: Ichikawa, Takanori, et al.
Publicado: (2019)

A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab
por: Lee, Ju Ho, et al.
Publicado: (2022)

Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis
por: Hu, Qiongyi, et al.
Publicado: (2019)

Successful treatment with tacrolimus of refractory adult-onset Still's disease
por: Ohe, Masashi, et al.
Publicado: (2014)

A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab
por: Lawless, Dylan, et al.
Publicado: (2018)

A Case Report on Adult-Onset Still’s Disease Successfully Treated With Tocilizumab: A Brief Review on its Safety and Efficacy
por: Nagalli, Shivaraj, et al.
Publicado: (2020)

Current and emerging biological therapy in adult-onset Still’s disease
por: Ma, Yuning, et al.
Publicado: (2021)

Two cases of multiple-drug-resistant adult-onset Still's disease treated successfully with tocilizumab - the relationship between interleukin 6 and 18
por: Sato, Kojiro, et al.
Publicado: (2012)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease
por: Tsuji, Yoshika, et al.
Publicado: (2015)

Myocarditis as the Initial Presentation of a Refractory Adult-Onset Still’s Disease
por: Pina Gonçalves, Nuno, et al.
Publicado: (2022)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
por: Donnelly, Jonathan P., et al.
Publicado: (2021)

Autoimmune hepatitis complicated by adult‐onset Still's disease during treatment with tocilizumab: A case report from acute onset to recurrence
por: Uchihara, Daiki, et al.
Publicado: (2023)

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease
por: Levy, Ofer, et al.
Publicado: (2022)

Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still’s disease
por: Hu, Qiongyi, et al.
Publicado: (2019)

Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
por: Akiyama, Kaho, et al.
Publicado: (2021)

Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review
por: Watanabe, Eri, et al.
Publicado: (2016)

Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature
por: Masui-Ito, Asami, et al.
Publicado: (2017)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Pregnancy Outcomes in Patients With Adult-Onset Still's Disease: A Cohort Study From China
por: Wang, Zhihong, et al.
Publicado: (2020)

Adult-Onset Still’s Disease
por: Mitrovic, Stéphane, et al.
Publicado: (2019)

Adult-Onset Still’s Disease
por: Efthimiou, Petros, et al.
Publicado: (2018)

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
por: Hwang, Sungeun, et al.
Publicado: (2021)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still’s Disease From Sepsis
por: Tian, Rui, et al.
Publicado: (2021)

Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qd992dvujtml37v7mtpsn6p59h